Lokhu kuhlolwa okubaluleke kakhulu kokuhlola kungasiza ekunqumeni uhlelo lwakho lwezokwelapha
Ukutholakala kokuqala komdlavuza webele kusindisa izimpilo futhi ukuxilongwa kwangaphambili ngokuvamile kusho ukwelashwa okunzima kakhulu. Kodwa i-oncologist yakho yayiyokwazi kanjani ukuthi imithi yokwelapha ingakuvimbela ngempela ukubuya komdlavuza wakho? I-Oncotype DX iyivivinyo lokuhlola lokubalulekile elikusiza wena kanye ne-oncologist yakho ukuthi unqume ukuthi yilu phi uhlelo lwezokwelapha oluzophumelela kakhulu ekuvimbeleni ukuphindaphinda umdlavuza noma ukusiza ukuphatha isifo sakho.
Ukuhlolwa kwe-Oncotype DX For Cancer Breast
Ukuze lolu hlelo luhlinzekwe, udokotela wakho uzohlola ukuthi ungumuntu ozohlolwa kuloluhlolo ngokubheka lezi zinqubo:
- I-Estrogen-receptor (isrogen-fueled) umdlavuza webele
- Isigaba 1 noma Isigaba 2
- I-node negative (i-lymph nodes ecacile emdlalweni)
Lokhu kuhlola kuhlola amasampula wezicubu zakho zesisu futhi ulinganisa ngeqoqo elithile lezakhi zofuzo ezingathonya ithuba lokuphindaphinda phakathi neminyaka eyishumi emva kokuxilongwa kwakho kwangempela. Lesi silinganiso sibizwa ngokuthi isiqephu sakho sokuphinda.
Amazinga Wokuhlola I-Cancer:
Igazi lakho kanye nezicubu zizohlolwa ngezindinganiso eziningana ukucacisa ukuxilongwa kwakho okuyingqayizivele. Imiphumela yalezi zivivinyo ithinta izinketho zakho zokwelapha. Izivivinyo zenzelwe:
- Usayizi we-tumor
- Ibanga le-Tumor (elihamba kancane noma elikhulayo)
- Isimo se-lymph node (metastasis)
- Ama-hormone receptors
- Isimo se-HER2
- Isimo se-menopausal
Yonke yale miphumela yokuhlola iveza ukuxilongwa , kodwa ngaphandle kolwazi lofuzo, ingozi yakho yokuphindaphinda inzima ukuyiqonda.
Ulwazi lwakho lofuzo, ngaphezu kwazo zonke izikolo zakho zokuhlola, lunikeza isithombe esicacile sokuthi ungadinga yini imithi yamakhemikhali noma cha ukuvikela ukubuyela komdlavuza wakho webele.
Ingozi Yokuphindaphindiwe Ngokususelwa Ekubonisweni KwamaGenesis
Isikweletu sakho sokuphinda sizobe sisekelwe ekuboniseni izakhi zofuzo ezingama-21, ezingu-16 zazo ezihlobene nomdlavuza futhi ezinhlanu zazo zibhekisela kuzo.
Izakhi zofuzo zihlanganiswe ngomsebenzi: ukwanda, ukuhlasela, ama-hormone receptors (estrogen ne-progesterone) nezici zokukhula. Imiphumela yokuhlolwa komuntu ngamunye iyohluka, kepha izowela kwesinye sezigaba ezintathu:
- Ingozi ephansi
- Ingozi ephakathi
- Ingozi enkulu
Yeka ukuthi ingozi yokuphindaphinda ithinta kanjani izinqumo zokwelapha
Iziguli ezinobungozi obuphansi bokuphindaphinda kungenzeka zingadingeki noma yiziphi i-chemotherapy futhi zingakwazi ukuthatha ukwelashwa kwe-hormone njengokwelashwa kwabo kokulandela emva kokuhlinzwa. Uma usuphakathi kwezigaba ezinobungozi obuphezulu, ungadinga ukwelashwa kwamakhemikhali kanye ne-hormone therapy ukuze uqhubeke unciphisa ingozi yokuphindaphindiwe. Ezinye izinto eziningi ezifana nobudala, ubukhulu be-tumor kanye ne-hormone receptor isimo zizocatshangelwa ngaphambi kokuba unqume ohlelweni lwezokwelapha, kodwa ucwaningo luye lwabonisa ukuthi imiphumela evela kuhlolo lwe-Oncotype DX yindlela ephakeme kakhulu yokuphindaphindiwe.
Okunye Isinqumo Sokwelapha Izinqumo Ezikuthinta Wena
Lokhu kuhlola akutshelanga udokotela wakho ukuthi yiluhlobo luni lwezidakamizwa ze-chemotherapy oluzosetshenziswa, kungakhathaliseki ukuthi uludingayo yini u- Herceptin , noma ngabe uzodinga ukwelashwa kwama-radiation. Lezo zinqumo zizotholakala eminye imiphumela yokuhlolwa.
Ukumboza Izindleko Zokuhlolwa Kwe-Genetic Assay
I-Medicare kanye nezinkampani eziningi zomshuwalense wezempilo zangasese zizosiza ukumboza izindleko zohlolo lwe-Oncotype DX.
Hlola nomhlinzeki wakho womshuwalense ukuze uthole ukuthi uhlolwe yini kuloluhlolo. Ukuze ufanelekele lolu hlelo, kufanele ube nesiteji soku-1 noma isigaba se-node-negative, isifo somdlavuza we-estrogen se-receptor-positive. Ukuhlolwa kuhlaziywa futhi kuhlinzekwe yi-Genomic Health futhi uma ungaqinisekisiwe noma ungaphansi kwe-insured, ungafuna ukuxhumana nabo mayelana nosizo lwezezimali.
Imithombo:
"I-Cancer Diagnostics: Ukwazisa Ukuthuthukiswa KwamaKhansela Okunakekelwa Ngomdlavuza". I-National Cancer Institute. 2006.
> I-Genomic Health. Mayelana ne-Oncotype DX. Ukwaziswa kweziguli kanye nabanakekeli, ngo-2008.